in-hospital mortality. The odds ratio (OR) and the 95% confidence interval (CI) were also calculated. A p <0.05 was considered to indicate statistical significance. All analyses were performed using statistical software, Dr. SPSS 2/Windows (SPSS Inc, Chicago, Illinois, USA).
results

Study population and baseline characteristics
Between January 2003 and August 2011, there were 259 patients with Stanford type B AAD admitted to our institution. Nine patients were excluded from the study because of maintenance hemodialysis. Thus, a total of 250 Stanford type B AAD patients were included in this analysis. The mean age was 68.2 ± 13.1 years, with the majority of patients being male. 158 (63.2%) had a history of hypertension, 53 (21.2%) had a history of dyslipidemia, 22 (8.8%) had a history of diabetes mellitus and 156 (62.4%) had a history of smoking. Compared with the patients with eGFR ≥60 ml/min/1.73m 2 , the patients with eGFR <60 ml/min/1.73m 2 were significantly older. Time intervals between onset of symptom and admission were similar in the patients of both groups.
C-reactive protein (CRP) on admission was significantly higher in the patients with eGFR <60 ml/min/1.73m 2 than the patient with eGFR ≥60 ml/min/1.73m 2 . EGFR of the overall patients was 72.2 ± 27.8 ml/min/1.73m 2 . The rate of acute renal failure in the patients with eGFR <60 ml/min/1.73m 2 was higher than the patients with eGFR ≥60 ml/min/1.73m 2 . CT findings were similar in the patients of both groups. All patients were initially subjected to intense medical therapy that focused on blood pressure lowering; of these, 232 patients (92.8%) continued to receive medical therapy for treatment of their Stanford type B AAD whereas 18 (7.2%) underwent surgery. While both groups were similar in many respects except for calcium channel blocker and angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACE-I/ARB) in medical therapy. Calcium channel blocker and ACE-I/ARB were more often prescribed in the patients with eGFR ≥60 ml/min/1.73m 2 ( Table 1) .
The mean duration of hospitalization was 28.9 ± 20.2 days. In-hospital complications such as stroke, intestine ischemia, limb ischemia and rupture were similar in both groups. The rate of acute respiratory distress syndrome was higher in the patients with eGFR <60 ml/min/1.73m 2 than the patients with eGFR ≥60 ml/min/1.73m 2 . Compared with the patients with eGFR ≥60 ml/min/1.73m 2 , the patients with eGFR <60 ml/min/1.73m 2 were significantly containing both true and false lumens, (3) CT confirmation of that the ascending aorta was not involved and (4) not on maintenance hemodialysis. Definitions of the following clinical criteria include: hypertension: blood pressure ≥140/90 mmHg or treatment for hypertension before admission; dyslipidemia: LDL-cholesterol level ≥140 mg/dl or treatment for dyslipidemia before admission; diabetes mellitus: treatment for diabetes mellitus before admission and smoking: ever smoking habit. Baseline blood sample was obtained on admission to the coronary care unit. Estimated glomerular filtration rate (eGFR) is widely recognized as a useful marker to evaluate renal function. eGFR was calculated as follows; eGFR (male) = 194 × Scr -1.094 × age -0.287 ml/min/1.73m 2 , eGFR (female) = eGFR (male) × 0.739 (Scr: serum creatinine). 8) Patients were divided into two groups: eGFR >/= 60 ml/min/1.73m 2 group and eGFR <60 ml/ min/1.73m 2 group. In accordance with the Acute Dialysis Quality Initiative (ADQI) Group, 9) acute renal failure was defined for increased Scr within 2 days on admission 1.5 times or greater.
Computed Tomography
Computed tomography with a bolus intravenous injection of contrast medium was performed on admission in all 250 patients. The initial examination was used in the statistical analysis. At first, the extension of the dissection was evaluated and a Stanford type was confirmed, then the false lumen closure status was evaluated. The thrombosed type was defined as a false lumen that was not enhanced entirely by contrast whereas the non-thrombosed type was defined as a false lumen that was enhanced by contrast. In addition, partial enhancement of the false lumen was defined as the non-thrombosed type and intramural hematoma of the aorta was included in the definition of the thrombosed type. The maximum aortic diameter of the dissected aorta was measured in all patients. Decreased enhancement of kidney was defined as an enhancement of kidney decreased by narrowed or obstructed renal artery due to intimal flap or false lumen etc.
Statistical analysis
Quantitative variables were presented as mean ± SD and categorical variables as percentages. Continuous variables were compared with the Student's t-test and categorical data with the Fisher's exact or chi-square tests. Univariate and multivariate logistic regression analyses were performed to identify the predictors of intestine ischemia ( Table 3) .
Predictors for in-hospital mortality
In univariate logistic regression analysis, age (each having a 10 years increment: OR 1.790, 95% CI 1.150 -2.785, p = 0.010), diabetes mellitus (OR 3.235, 95% CI 1.075-more likely to die in hospital ( Table 2 ). In-hospital mortality occurred in 24 patients. Twelve patients died because of renal failure and respiratory failure. Four patients died because of aortic rupture and the other patients died because of gastrointestinal hemorrhage, limb ischemia, respiratory failure, severe infection or Table 2 Outcomes 
dIscussIon
While renal dysfunction independently predicted higher mortality in patients with acute coronary syndrome, 10, 11) predictors of in-hospital events in Stanford type B AAD patients including renal function have not been clearly established. The present study results showed that a renal dysfunction was the independent predictor of in-hospital mortality for the patients with Stanford type B AAD. Thus, higher risk patients might be identified by acquiring eGFR in cases of confirmed dissected descending aorta.
We could have discriminated chronic kidney disease and acute kidney injury clearly if we had the data about renal function before admission. Since time intervals between onset of symptom and admission were relatively short and CT findings were similar in the patients of both groups, we speculated that low eGFR on admission was 9.740, p = 0.037), peak CRP (OR 1.155, 95% CI 1.063-1.256, p = 0.001), maximum aortic diameter measured by an initial CT (each having a 10 mm increment: OR 1.684, 95% CI 1.063-2.667, p = 0.026), decreased enhancement of kidney (OR 5.791, 95% CI 2.080-16.129, p = 0.001), acute renal failure (OR 4.718, 95% CI 1.960-11.352, p = 0.001) and eGFR <60 ml/min/1.73m 2 (OR 3.392, 95% CI 1.435-8.020, p = 0.005) were significant predictors of in-hospital mortality ( Table 4) .
In multivariate logistic regression analysis, the significant predictors on admission were age (each having a 10 years increment: OR 1.575, 95% CI 1.078-2.864, p = 0.024), maximum aortic diameter measured by an initial CT (each having a 10 mm increment: OR 1.740, 95% CI 1.029-2.940, p = 0.039), decreased enhancement of kidney (OR 7.716, 95% CI 2.335-25.501, p = 0.001) and eGFR <60 ml/min/1.73m 2 on admission (OR 2.782, 95% CI 1.062-7.283, p = 0.037) ( Table 5 ). due to basal renal dysfunction. The usage of calcium channel blocker and ACE-I or ARB in the group with eGFR <60 ml/min/1.73m 2 was infrequent. Since the rate of acute renal failure in the patients with eGFR <60 ml/min/1.73m 2 on admission was higher than the patients with eGFR ≥60 ml/min/1.73m 2 , we thought that was because those patients were intolerant to the medications. This study was not a prospective study and we controlled the blood pressure of the patients with the target blood pressure, so we cannot exclude the possibility that the patients required less amount of medication due to relatively well-controlled blood pressure.
Predictors of in-hospital mortality
In an International Registry of Acute Aortic Dissection (IRAD) report, a dilated aorta (≥6 cm) was associated with in-hospital mortality in univariate analysis. 12) Our study also confirmed that the maximum aortic diameter was a determinant of in-hospital mortality in univariate and multivariate analysis.
A patent false lumen during the acute phase is reported to be a predictor of aortic dissection enlargement. 13) The non-thrombosed type was not a significant predictor of in-hospital events in univariate analysis in this study. One of the explanations about this difference is that the present study only adopts initial CT findings and does not provide information about gradual enlargement of the aorta during hospitalization. Further research is warranted to determine the efficacy of serial CT analyses in this clinical setting.
As aortic dissection is associated with systemic inflammation, fibrinolytic marker D-dimer, heart-type fatty acid-binding protein and inflammatory markers such as white blood cell (WBC) and CRP are known to increase in the acute phase. 14-17) Sugano, et al., reported that the greater peaks of CRP levels predicted poor clinical outcomes. 18) In our study, neither WBC nor CRP on admission was a significant predictor for in-hospital mortality. However, peak CRP was a significant predictor for in-hospital mortality. One explanation for this difference might be the timing of the CRP measurements. The initial evaluation of the WBC and CRP might be less important than the peak evaluation of that for risk stratification.
Multiple organ failure (MOF) including renal failure and respiratory failure was more frequent than rupture as a cause of in-hospital mortality in the patient with type B AAD. Renal function after admission tended to deteriorate in the patients with renal dysfunction on admission. The patients with renal dysfunction tended to have respiratory failure including ARDS. Since MOF was often complicated with respiratory failure for renal dysfunction, blood pressure lowering therapy preventing deterioration of renal function such as moderate blood lowering might lead to reduce the MOF and mortality.
Intravascular ultrasound-guided percutaneous fenestration of the intimal flap in the dissected aorta can effectively relieve the patient's symptom. 19) Nishida, et al., reported that a case of acute Stanford type B thoracic aortic dissection complicated with malperfusion, which was successfully treated with emergent thoracic endovascular aortic repair. 20) The decreased enhancement of kidney related with renal dysfunction and predicted to the in-hospital mortality. Hence treatment to improve renal flow such as fenestration or endovascular repair might be useful for the decrease of in-hospital mortality in patients with Stanford type B AAD.
Study limitations
This study was performed at a single center, thus posing a risk for possible patient selection bias. Furthermore, these are observational data, and the conclusions are not based on prospective and randomized study results. Although the patient number used in this study was not low, it might have been underpowered for identifying other predictive factors. Our analyses of patient outcomes were based on the results from the initial admission. For example, the creatinine levels on admission used to calculate eGFR were not discriminate chronic and acute kidney injury that may occur as a result of hemodynamic compromise and inflammatory response. More recently, it has been shown that cystatin C-based formulas are more reliable and reproducible than creatinine-based ones, but cystatin C was not available when this database started to collect. 21, 22) The available data are limited to in-hospital mortality and do not provide information on mid-term to long-term outcomes.
conclusIons
The present study results identified a renal dysfunction on admission as the independent predictor of in-hospital mortality in the patients with Stanford type B AAD. Further investigations are needed to evaluate therapies and strategies for decreasing the deterioration of renal function to improve in-hospital mortality in patients with Stanford type B AAD.
